BridgeBio Pharma, Inc. (BBIO)

74.50 -1.11 (-1.47%) USD  |  NASDAQ  |  Dec 30, 14:30
More

BridgeBio Pharma Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Supernus Pharmaceuticals, Inc. --
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade